ProCE Banner Activity

Expert Q&A – Current Topics in Obstructive Sleep Apnea: Treatment of Excessive Daytime Sleepiness

Text Module

During PCE's recent Pulmonary Bootcamp, attendees had the chance to ask our expert faculty a variety of questions. Here, Karl Doghramji, MD and Ann Cartwright, PA-C, faculty for the presentation Current Topics in Obstructive Sleep Apnea: Treatment of Excessive Daytime Sleepiness provide responses to the questions about excessive daytime sleepiness. We hope you will find their responses relevant to your practice.

In Partnership With the Association of Pulmonary Advanced Practice Providers

APAPP Logo

Released: December 10, 2021

Expiration: December 09, 2022

Share

Acknowledgement

This program is cosupported by educational grants from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson; Genentech, a member of the Roche Group; GlaxoSmithKline; Jazz Pharmaceuticals, Inc.; and Mylan Specialty L.P.

This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Provided by

ProCE Banner

Disclosure

Ms Cartwright has no relevant financial relationships to disclose.

Dr Doghramji: consulting fees: Eisai, Idorsia, Imbrium, Pfizer; contracted research/consulting fees: Harmony, Jazz, Inspire; ownership interest: Merck.

Additional Information

Program Medium

This program has been made available online.